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Legislation for smoke-free workplaces and health of bar workers in
Ireland: before and after study
Shane Allwright, Gillian Paul, Birgit Greiner, Bernie J Mullally, Lisa Pursell, Alan Kelly, Brendan Bonner, Maureen
D’Eath, Bill McConnell, James P McLaughlin, Diarmuid O’Donovan, Eamon O’Kane, Ivan J Perry
Abstract
Objectives To compare exposure to secondhand smoke and
respiratory health in bar staff in the Republic of Ireland and
Northern Ireland before and after the introduction of
legislation for smoke-free workplaces in the Republic.
Design Comparisons before and after the legislation in
intervention and control regions.
Setting Public houses in three areas in the Republic
(intervention) and one area in Northern Ireland (control).
Participants 329 bar staff enrolled in baseline survey; 249
(76%) followed up one year later. Of these, 158 were
non-smokers both at baseline and follow-up.
Main outcome measures Salivary cotinine concentration, self
reported exposure to secondhand smoke, and respiratory and
sensory irritation symptoms.
Results In bar staff in the Republic who did not themselves
smoke, salivary cotinine concentrations dropped by 80% after
the smoke-free law (from median 29.0 nmol/l (95% confidence
interval 18.2 to 43.2 nmol/l)) to 5.1 nmol/l (2.8 to 13.1 nmol/l)
in contrast with a 20% decline in Northern Ireland over the
same period (from median 25.3 nmol/l (10.4 to 59.2 nmol/l) to
20.4 nmol/l (13.2 to 33.8 nmol/l)). Changes in self reported
exposure to secondhand smoke were consistent with the
changes in cotinine concentrations. Reporting any respiratory
symptom declined significantly in the Republic (down 16.7%,
− 26.1% to − 7.3%) but not in Northern Ireland (0% difference,
− 32.7% to 32.7%). After adjustment for confounding,
respiratory symptoms declined significantly more in the
Republic than in Northern Ireland and the decline in cotinine
concentration was twice as great.
Conclusion The smoke-free law in the Republic of Ireland
protects non-smoking bar workers from exposure to
secondhand smoke.
Introduction
In response to the evidence on the adverse effects of passive
smoking on health,1–3 on 29 March 2004 the Republic of Ireland
introduced a comprehensive smoke-free law, covering all indoor
workplaces, including bars and restaurants.4–6 Introduction of this
legislation in the Republic but not in neighbouring Northern
Ireland, with its comparable population, environment, and
culture, was a form of “policy randomisation,”7 creating a natural
experiment for identifying effects of the new law.
To date few studies have investigated whether legislation for
smoke-free workplaces protects the health of workers. Cross sec-
tional surveys before and after similar legislation in Finland in
1995 showed a decline in self reported exposure to secondhand
smoke in workers from several non-hospitality workplace
settings.8 Some of the highest and most sustained occupational
exposures to secondhand smoke occur in bar staff,9 10 with non-
smoking areas providing only limited protection.11 Carbon mon-
oxide concentrations in pubs in Galway indicated high exposure
in Irish bar workers.12 Eisner and colleagues examined 53 bar
staff in San Francisco one month either side of the 1998
statewide law in California banning smoking in bars.13 They con-
cluded that the law was associated with a rapid improvement in
respiratory health.
We examined the impact on bar staff of a national workplace
smoke-free law by using laboratory assessment of exposure to
secondhand smoke and by controlling for unrelated secular
trends. We compared exposure to secondhand smoke and respi-
ratory health in bar staff in rural and urban areas of the Repub-
lic of Ireland before and after the law and compared these
changes with changes observed in Northern Ireland.
Methods
We enrolled staff working in pubs in the Republic and Northern
Ireland in a baseline survey in the six months leading up to the
ban (September 2003 to March 2004) and followed them up one
year later (September 2004 to March 2005) to assess changes in
exposure to secondhand smoke and symptoms (natural
experiment).
Sample selection
Three areas in the Republic (Dublin, Cork, and County Galway)
were selected to represent different types of pub environment,
together with one area in the north west of Northern Ireland.
Sampling procedures were adapted to local circumstances to
maximise follow-up. In Dublin, we selected city centre and subur-
ban pubs. The main trade union for Dublin bar workers
(Mandate) forwarded our letter asking members to contact the
research team if they were interested in participating. All pubs on
randomly selected streets in Cork city were invited to participate
and up to two bar staff were randomly selected from each pub. In
Galway, we identified rural and family owned pubs by selecting
electoral districts with populations of less than 1500. In
Northern Ireland, we selected pubs from Derry City Council
area and the adjoining rural Strabane and Limavady Council
areas. All staff present in the Galway and Northern Ireland pubs
on the day of the survey were asked to participate.
Although we enrolled both smokers and non-smokers, this
analysis is restricted to participants who were non-smokers at
both baseline and follow-up.
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Conduct of survey
We invited Dublin bar staff to a hospital respiratory laboratory
for salivary cotinine testing and administration of the
questionnaire. Bar staff from the three other areas and the few
Dublin staff who did not wish to attend the laboratory were
interviewed in their workplace (pub). Most follow-up interviews
were conducted in the same month as the baseline survey; at
least two attempts at contact were made. GP trained all the inter-
viewers.
Exposure to secondhand smoke
Salivary cotinine—Non-stimulated saliva samples (about 1 ml)
were collected according to the protocol used in the Health Sur-
vey for England.14 Samples were frozen and sent in batches to
ABS Laboratories, London, who performed cotinine assays blind
with a rapid gas-liquid chromatographic method suitable for use
in non-smokers.15 We ascertained smoking status because active
smoking is the main influence on cotinine concentrations. As
cotinine half life is about 20 hours,16 length of time since last
working also impacts on cotinine concentrations. This was there-
fore recorded for the Dublin participants. Participants inter-
viewed in pubs were asked what time they started the current
shift. The number of hours worked in the past two days was
recorded for all participants.
Self reported exposure—We recorded hours of exposure to sec-
ondhand smoke at work and in total (including work, home, and
other regular activities) over the past seven days and whether
participants lived with a smoker.
Respiratory and sensory symptoms—We used questions devel-
oped by Eisner, Smith, and Blanc to get information on
symptoms of respiratory and sensory irritation. Respiratory
questions were adapted from the validated bronchial symptoms
questionnaire of the International Union against Tuberculosis
and Lung Disease.13
Statistical analysis
A nationally representative survey of the US population used
85.2 nmol/l (15 ng/ml) serum cotinine as a cut off for
distinguishing smokers from non-smokers.17 Heavy exposure to
secondhand smoke, however, may produce saliva concentrations
as high as 177.8 nmol/l (31.3 ng/ml).10 Given the high exposures
in bar workers,9 10 and as salivary concentrations are 25% higher
than serum concentrations,18 we defined non-smokers as those
who reported being former smokers or who had never smoked
and had salivary cotinine concentration < 113.6 nmol/l (20
ng/ml).We excluded people who claimed to be non-smokers but
had salivary cotinine concentration ≥ 113.6 nmol/l as we
considered them to be active smokers.
To measure any changes, we analysed symptoms individually,
grouped into two dichotomous variables (any respiratory symp-
toms and any sensory symptoms), and as two symptom scores
(total number of respiratory symptoms and total number of sen-
sory symptoms reported by each individual).
Analyses (changes within pairs) were restricted to partici-
pants who took part in both baseline and follow-up surveys, who
were still working in a pub, and who did not change their smok-
ing status between baseline and follow-up. In before and after
comparisons, differences between groups in characteristics that
did not change, such as age and length of time in the bar trade
(all increase by one year) and sex, are controlled internally. Uni-
variate and bivariate analyses were conducted with JMP 5.0.1
(SAS Institute, Pacific Grove, CA), SPSS 12.0.1 (SPSS, Chicago,
IL) and Mathematica 5.2 (Wolfram Research, Champaign, IL). As
the data were skewed, we have presented medians and interquar-
tile ranges for continuous data. We compared paired differences
using Wilcoxon signed rank test or McNemar’s 2 test for bivari-
ate analyses and non-paired differences using Wilcoxon rank
sum test, Pearson 2, or Fisher’s exact test.
The requirement to compare the Republic with Northern
Ireland while simultaneously testing outcomes (continuous—
such as cotinine—or count—such as number of symptoms) at
follow-up versus at baseline, together with the inclusion of both
time varying covariates (such as hours worked in the past two
days) and time constant covariates (such as sex), limits modelling
possibilities to specific forms of generalised estimation
equations.19 We used versions of generalised estimation
equations for multiple regression (for changes per person in
cotinine before and after the ban) and for Poisson regression
(rate ratio for changes per person in the reported numbers of
symptoms before and after the ban) using Stata 9 (StataCorp,
College Station, TX). All covariates were tested in the models, but
we retained only those that proved significant, plus age and sex.
Interaction terms between region and time period were always
fitted and retained in the model if the associated P value was less
than 0.10.
Results
We enrolled 329 bar staff at baseline and 249 in the follow-up
survey (table 1). Forty eight were not eligible for follow-up, 23
could not be contacted after several attempts, and nine refused,
giving a follow-up rate of 89% of those eligible or 76% overall in
the Republic, and 88% and 71% in Northern Ireland. In total 226
participants in the baseline survey and 213 in the follow-up sur-
vey provided analysable saliva samples; 205 provided analysable
samples in both surveys.
Most participants (161/249, 65% at baseline) were non-
smokers. We restricted analyses to the 158 who were still
Table 1 Participants in baseline and follow-up surveys of bar staff before
and after smoking ban
Republic of Ireland Northern Ireland
Enrolled in baseline survey 288 (207 from 140 pubs and
81 from Mandate*)
41 (41 from 24 pubs)
Not eligible for follow-up:
Total 40 8
No longer in bar trade 36 4
Moved 3 4
Died 1 0
Not followed up:
Total 28 4
Not contactable 19 4
Refused 9 0
Follow-up rate 76% (220/288) 71% (29/41)
Follow-up rate in those eligible
for follow-up
89% (220/248) 88% (29/33)
Cotinine concentrations
Available at baseline and
follow-up
176 29
Not available†:
Total 59 0
Insufficient 20 0
Contaminated 11 0
Refused 28 0
Non-smokers
At baseline and follow-up 138 20
With cotinine concentrations at
both surveys
111 20
*Mandate is the main trade union for Dublin bar workers.
†8 participants had no cotinine value at baseline, 21 had no cotinine value at follow-up, and
15 had no cotinine at either time.
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non-smokers at follow-up. Most participants were men.
Participants from the Republic were older and had been working
in the current pub for longer (table 2).
Those not followed up (n = 80) were significantly younger
and more likely to be women, to smoke, to have worked for a
shorter time in the current bar, and to have said they had asthma
diagnosed by a physician than those followed up (data not
shown).
Salivary cotinine concentrations declined significantly in
both regions, but with a much greater decline in the Republic
(80% v 20% in Northern Ireland). Cotinine concentrations for
almost all the non-smokers in the Republic (106/111) fell com-
pared with 14 out of 20 in Northern Ireland.
Self reported exposure to secondhand smoke was high
before the ban, with smoke at work accounting for by far the
greatest exposure (table 3). Work related exposure dropped to a
far greater extent in the Republic (median of 40 v 0 hours in the
past week, P < 0.001) than in Northern Ireland (median 42 v 40
hours, P = 0.02). Exposures outside work also dropped
significantly in the Republic (median 4 v 0 hours, P < 0.001) but
increased in Northern Ireland (0 v 2.5 hours, P = 0.41).
At baseline 65% of non-smokers in the Republic reported
one or more respiratory symptom (table 4). This dropped by
25% to 49% (P = 0.001) at follow-up. After the ban, significantly
fewer reported cough during the day or night (P = 0.004) or pro-
duction of phlegm (P = 0.002). Similarly, after the ban, reporting
any sensory symptom dropped from 67% to 45% (P < 0.001),
reflecting significant declines in reporting red eyes (P < 0.001)
and sore throat (P = 0.004). In Northern Ireland, the proportion
reporting any respiratory symptom was lower at baseline (45%)
than in the Republic and remained at 45% after the ban,
although reporting any sensory symptom declined from 75% to
55% (P = 0.13).
We modelled changes in cotinine concentrations and in the
number of respiratory and sensory symptoms (table 5). After
adjustment for relevant covariates, cotinine concentrations in
non-smokers in the Republic dropped by 71% (from 35.8 to 10.2
nmol/l), more than twice as much as in Northern Ireland (34%
from 35.2 to 23.3 nmol/l) (table 6).
Table 6 also shows that the adjusted rate ratio for the number
of respiratory symptoms (symptoms at follow-up relative to
symptoms at baseline) in the Republic dropped (from 1.33 to
0.98), while in Northern Ireland it increased by 16% (from 0.67
to 0.83). The adjusted rate ratio for the number of sensory symp-
toms dropped substantially in both regions (by 50% in the
Republic and by 44% in Northern Ireland).
Discussion
Main findings
This study shows that the smoking ban in the Republic of Ireland
has led to a clear reduction in self reported exposure to second-
hand smoke in and outside work. In non-smokers, salivary coti-
nine concentrations dropped by 80% and respiratory and
sensory symptoms were significantly fewer. Smaller reductions
were observed in Northern Ireland. The adjusted reduction in
cotinine concentration was twice as great in the Republic as in
Northern Ireland and respiratory symptoms also declined to a
significantly greater extent.
It has been suggested that banning smoking in pubs and res-
taurants would lead to increased smoking in the home.20
Although we did not ask specifically about exposure at home,
our data do not support this contention as self reported
exposure to secondhand smoke outside work dropped
significantly in the Republic, but increased in Northern Ireland
(table 3).
The unexpected improvements in Northern Ireland may be
explained by a decline in the pub trade. At follow-up,
participants from Northern Ireland reported working fewer
hours in the past two days (12 hours v 10, table 3). An economic
downturn in the north west region,21 avoidance of drink driving,
and stricter enforcement of regulations on underage drinking
may be contributory factors. Some of the same factors may also
Table 2 Baseline characteristics of non-smoking* bar staff enrolled in both
baseline and follow-up surveys. Values are medians (interquartile ranges)
unless stated otherwise
Republic of Ireland
(n=138)
Northern Ireland
(n=20) P value†
Age (years) 45.5 (35.0-54.9) 36.1 (20.9-43.8) <0.001
No (%) of women 23 (17) 5 (25) 0.36
Time working in current bar
(years)
9 (4-22) 2 (1.0-9.5) 0.002
Hours worked/ week in current
job
40 (39.0-50.0) 40 (21.0-58.8) 0.46
No (%) with history of asthma
diagnosed by physician
15 (11) 1 (5) 0.70
No (%) currently receiving
asthma prescription
9 (7.9) 0 0.35
*Non-smoker defined as participants who said they did not smoke or had given up and had
salivary cotinine concentrations <113.6 nmol/l. Excludes participants who changed smoking
status between surveys.
†P value for comparison of medians (Wilcoxon rank sum test) and categorical variables
(Pearson 2 or Fisher’s exact test) at baseline and follow-up.
Table 3 Exposure to secondhand smoke in non-smokers* at baseline and
follow-up surveys in the Republic of Ireland (n=138) and Northern Ireland
(n=20). Values are medians (interquartile ranges) unless stated otherwise
Baseline Follow-up
P
value†
Difference (95%
CI)‡
Republic of Ireland
Secondhand smoke exposure:
Salivary cotinine (nmol/l)§ 29.0
(18.2-43.2)
5.1
(2.8-13.1)
<0.001 −22.7
(−26.7 to −19)
Self reported exposure:
Hours exposed at work (pub
or bar) during past 7 days
40 (39-50) 0 <0.001 −40
(−47 to −41.5)
Hours exposed outside work
(domestic or social) during
past 7 days
4 (0-10) 0 (0-2) <0.001 −1.25
(−4 to −1.5)
No (%) living with smoker 37 (26.8) 36 (26.1) 0.79 −0.7
(−6.9 to 5.5)
Hours worked in past 2 days 13 (9-19.5) 13 (7.1-18) 0.01 −2 (−3 to −0.5)
Northern Ireland
Secondhand smoke exposure:
Salivary cotinine (nmol/l)§ 25.3
(10.4-59.2)
20.4
(13.2-33.8)
0.05 −5.7
(−21.3 to −3.7)
Self reported exposure:
Hours exposed at work (pub
or bar) during past 7 days
42 (15-55) 40 (6.5-45) 0.02 −3
(−11.5 to −0.5)
Hours exposed outside work
(domestic or social) during
past 7 days
0 (0-10) 2.5 (0-18) 0.41 0 (−2.5 to 7.5)
No (%) living with smoker 6 (30) 6 (31.6) 1.00 0 (−19.9 to 19.9)
Hours worked in past 2 days 12 (0-19) 10 (4-14) 0.63 −1.25 (−6 to 3.3)
IQR=interquartile range.
*Non-smokers defined as participants who said they did not smoke or had given up and had
salivary cotinine concentrations <113.6 nmol/l at both baseline and follow-up surveys.
Excludes participants who changed smoking status between surveys.
†P value for comparison of medians (Wilcoxon signed rank test) and categorical variables
(McNemar 2 test) at baseline and follow-up.
‡Differences refer either to medians or percentages
§Values are for 131 participants (111 in the Republic of Ireland and 20 in Northern Ireland)
with cotinine concentrations at both baseline and follow-up survey.
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be operating in the Republic alongside the high cost of drinking
in pubs and a 9 pm watershed for people aged under 18, all con-
tributing to a downturn in the pub trade.6
Comparison with other studies
There have been few follow-up studies of bar workers. The San
Francisco study was small, based in a single city, and did not
include biomarkers for assessment of secondhand smoke.13
Follow-up studies in New York22 and Norway23 were not focused
(exclusively) on bar staff and had low follow-up rates. None
included a control population.
As in the San Francisco study,13 we found dramatic decreases
in self reported exposure to secondhand smoke at work and
reductions in respiratory and sensory symptoms. The reductions
in salivary cotinine concentrations in non-smoking hospitality
workers in New York22 were of a similar magnitude to those in
our study. They reported significant reductions in the numbers
of sensory symptoms but not of respiratory symptoms.
Preliminary results from Norway show significant reductions in
both respiratory and sensory symptoms.23
Strengths of study
We managed to enrol a large number of bar staff and our
follow-up rate was high. The study evaluated a national law, bar
staff were enrolled from three differing areas, and the inclusion
of Northern Ireland allowed us to control for secular trends
unrelated to the legislative change and hence estimate how
much of the change was due to the new law.
In bodily fluids, cotinine, with a half life of around 20 hours,16
is a good indicator of exposure to smoke over the previous two
to three days. We used a combination of cotinine and self
reported exposure as this is considered the best way of estimat-
ing exposure.24
The substantial declines in personal exposure of bar staff
reported here are corroborated by measurements of particulate
concentrations in pubs. Significant reductions (typically 60-80%)
were observed after the introduction of the workplace smoking
Table 4 Respiratory and sensory irritation symptoms at baseline and at
follow-up surveys among non-smokers* in the Republic of Ireland and
Northern Ireland (n=138 and 20). Values are numbers (percentages) unless
stated otherwise
No (%) with symptoms
P value† Difference (95% CI)‡Baseline Follow-up
Republic of Ireland
Respiratory symptoms:
Median (IQR) No of
symptoms
1 (0-2) 0 (0-2) 0.001 0 (−0.5 to 0)
Any symptom 90 (65) 67 (49) 0.001 −16.7 (−26.1 to −7.3)
Wheezing/whistling 29 (21) 27 (20) 0.86 −1.5 (−9.9 to 7.1)
Shortness of breath 22 (16) 22 (16) 1.00 0 (−8.2 to 8.2)
Cough, morning 29 (21) 20 (15) 0.14 −6.5 (−14.8 to 1.8)
Cough, rest of day or night 53 (38) 34 (25) 0.004 −13.8 (−23.1 to −4.5)
Phlegm production 59 (43) § 40 (29) 0.002 −14.7 (−24.0 to −5.4)
Sensory symptoms:
Median (IQR) No of
symptoms
1 (0-2) 0 (0-1) <0.001 −1 (−1.27 to −0.7)
Any symptom 93 (67) 62 (45) <0.001 −22.5
(−33.8 to −11.1)
Eyes, red or irritated 57 (41) 19 (14) <0.001 −27.5
(−37.4 to −17.7)
Nose, runny or sneezing 61 (44) 48 (35) 0.08 −9.4 (−19.8 to 0.9)
Throat, sore or scratchy 46 (33) 26 (19) 0.004 −14.5 (−24.3 to −4.7)
Northern Ireland
Respiratory symptoms:
Median (IQR) No of
symptoms
0 (0-1) 0 (0-1) 0.53 0 (−0.5 to 1)
Any symptom 9 (45) 9 (45) 1.00 0 (−32.7 to 32.7)
Wheezing/whistling 1 (5) 1 (5) 1.00 0 (−18.9 to 18.9)
Shortness of breath 5 (25) 3 (15) 0.69 −10 (−38.6 to 18.6)
Cough, morning 1 (5) 3 (15) 0.50 10.0 (−8.1 to 28.1)
Cough, rest of day or night 2 (10) 3 (15) 1.00 5.0 (−16.8 to 26.8)
Phlegm production 4 (20) 6 (30) 0.63 10.0 (−14.1 to 34.1)
Sensory symptoms:
Median (IQR) No of
symptoms
1 (0.3-2) 1 (0-1) 0.07 0 (−1 to 0.5)
Any symptom 15 (75) 11 (55) 0.13 −20.0 (−42.5 to 2.5)
Eyes, red or irritated 9 (45) 8 (40) 1.00 −5.0 (−31.8 to 21.8)
Nose, runny or sneezing 10 (50) 5 (25) 0.06 −25 (−49.0 to −1)
Throat, sore or scratchy 4 (20) 3 (15) 1.00 −5.0 (−35.8 to 25.8)
IQR=interquartile range.
*Non-smokers defined as participants who said they did not smoke or had given up and had
salivary cotinine concentrations <113.6 nmol/l at baseline and follow-up surveys. Excludes
participants who changed smoking status between surveys.
†P value for McNemar 2 test for paired comparison of individual symptoms and Wilcoxon
signed rank test for comparing median number of symptoms at baseline and follow-up.
‡Differences refer either to medians or percentages.
§Two respondents did not answer this question.
Table 5 Modelled changes in non-smokers. Figures are regression
coefficients (95% confidence intervals) for cotinine concentrations and rate
ratios (95% confidence intervals) for respiratory and sensory symptoms
Regression coefficient or
rate ratio (95% CI) P value
Cotinine concentrations (nmol/l) (n=131)
Region (Republic:Northern Ireland) 0.022 (−1.56 to 1.61) 0.978
Time period (follow-up:baseline) −1.99 (−3.64 to −0.36) 0.017
Live with smoker (yes:no) 1.62 (0.62 to 2.62) 0.002
Hours worked in past 2 days 0.07 (0.01 to 0.13) 0.011
Age (years) −0.03 (−0.07 to 0.001) 0.053
Sex (female:male) 0.94 (−0.28 to 2.16) 0.134
Interaction between region and time period −2.40 (−4.18 to −0.62) 0.008
Constant 6.19 (4.25 to 8.12) <0.001
Respiratory symptoms (n=158)
Region (Republic:Northern Ireland) 1.96 (1.11 to 3.48) 0.021
Time period (follow-up:baseline) 1.22 (0.72 to 2.08) 0.447
Age (years) 1.00 (0.99 to 1.01) 0.487
Sex (female: male) 0.44 (0.28 to 0.69) <0.001
Interaction between region and time period 0.60 (0.35 to 1.04) 0.070
Sensory symptoms (n=158)
Region (Republic:Northern Ireland) 1.14 (0.77 to 1.70) 0.507
Time period (follow-up:baseline) 0.57 (0.47 to 0.71) <0.001
Age (years) 0.99 (0.98 to 1.00) 0.063
Sex (female:male) 0.86 (0.60 to 1.22) 0.398
Hours worked in past week 0.99 (0.98 to 1.00) 0.089
Table 6 Modelled estimates (95% confidence intervals) for time period
within region
Baseline Follow-up
Cotinine concentration*
Republic of Ireland 35.8 (31.8 to 39.2) 10.2 (6.8 to 13.6)
Northern Ireland 35.2 (27.3 to 43.7) 23.3 (15.3 to 32.4)
Rate ratios for respiratory symptoms†
Republic of Ireland 1.33 (1.14 to 1.54) 0.98 (0.83 to 1.16)
Northern Ireland 0.67 (0.39 to 1.17) 0.83 (0.50 to 1.36)
Rate ratios for sensory symptoms‡
Republic of Ireland 1.19 (1.02 to 1.39) 0.69 (0.57 to 0.85)
Northern Ireland 1.09 (0.75 to 1.56) 0.65 (0.44 to 0.97)
*Adjusted for region, time period, living with smoker, hours worked in past 2 days, age, sex,
interaction between region and time period, and constant, all set to average values.
†Adjusted for region, time period, age, sex, and interaction between region and time period all
set to average values.
‡Adjusted for region, time period, age, sex, and hours worked in past week all set to average
values.
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ban in both Dublin (http://tri.ie/ResearchResults/tabid/61/
Default.aspx) and Galway pubs.25
Limitations of study
The lack of national or regional sampling frames precluded ran-
dom sampling. The low take up at baseline, a feature of other
studies in this setting,13 22 reflects the pervasive anxiety in the
trade at that time about the impending ban. Because we used
volunteer sampling, the cotinine concentrations and frequencies
of symptoms reported here may not be generalisable. By choos-
ing different types of pub from urban and rural areas, however,
we have provided an overall picture of the impact of the ban.
The small number not followed up differed from the overall
group but this does not compromise study validity because of the
paired design. Although the numbers enrolled from Northern
Ireland were small, they were sufficient to detect significant
changes.
Recommendations for further research
Although perceived health is important, objective testing of lung
function and longer follow-up are required to assess the long
term impact of the ban. Our results suggest that home exposure
may have declined after the ban. Incorporation of testing of sali-
vary cotinine concentrations in children into national longitudi-
nal studies would be an objective way to monitor future
exposures in countries considering the introduction of similar
legislation. Secondhand exposure to smoke in exempted
workplaces (such as prisons, psychiatric institutions, and
hospices) should be monitored to assess the need for protection
of their staff.
Implications of findings
The smoke-free workplace law in the Republic of Ireland has
provided protection for one of the most heavily exposed
occupational groups by reducing their exposure to secondhand
smoke both in and out of the workplace. The reduced exposure
has led to a decline in respiratory and sensory symptoms in non-
smokers. The increase in support for the law in the Republic
since its introduction, even among smokers, underpins its effec-
tiveness.26 These findings have implications for policy makers
and legislators in other countries currently considering the
nature and extent of their smoke-free workplace legislation.
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